LifeMine is reviving its fungal genome platform with $188M from Bill Gates, Jeff Bezos and RA Capital, and will soon…
OpenAI will give up to 100,000 academic researchers free access to frontier models, including 75-plus life-science tools for genomics and…
Scientists at Mount Sinai developed a gene set foundation model that learns how genes behave across thousands of biological contexts,…
AI is reshaping pharmaceutical R&D from target identification through clinical trial optimization, compressing drug discovery timelines and unlocking therapeutic targets…
ARPA-H has awarded up to $160 million to seven research teams to build AI-driven platforms for creating custom, individualized gene…